The association between preconception cannabis use and depression and anxiety during pregnancy - 10/06/23
, Jamie O. Lo b, Shauna Rakshe c, Andrea D. Hildebrand d, Olivia J. Doyle e, Kristen Mackiewicz Seghete e, Alice Graham eAbstract |
Objective |
Cannabis use among individuals of reproductive age has increased with cannabis legalization and heightened stress during the COVID-19 pandemic. Our study provides data on preconception cannabis use and cannabis use disorder (CUD) during the pandemic and models the association between preconception cannabis use and depression and anxiety during pregnancy.
Methods |
Data on substance use and depression and anxiety symptoms were collected from questionnaires and the Structured Clinical Interview for DSM-5 (SCID-5) from pregnant individuals in Oregon in 2019–2022. Linear regression was used to model the association between the frequency of preconception cannabis use and scores on the Center for Epidemiological Studies of Depression-Revised (CESD-R) and Beck Anxiety Inventory (BAI).
Results |
The prevalence of preconception cannabis use was 27.8% among 227 study participants. CUD was diagnosed in 19% of cannabis users, or 5.3% of the overall sample. Daily cannabis use, compared to rare/never use, was associated with increases in CESD-R (β = 6.22, p 0.029) and BAI (β = 4.71, p 0.045) scores.
Conclusions |
Cannabis use and CUD are common among individuals of reproductive age. Given the association between preconception cannabis use and depression and anxiety during pregnancy, more attention is needed on screening and counseling of cannabis use among people of reproductive age.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Preconception cannabis use in the 3 months prior to pregnancy is common. |
• | Cannabis use disorder is present in 1 in 5 individuals of reproductive age who use cannabis. |
• | In addition to impacts on reproductive health, preconception cannabis exposure has implications for perinatal mental health. |
• | Daily cannabis use during preconception is associated with greater depression and anxiety symptoms during pregnancy. |
Keywords : Cannabis, Marijuana, Preconception, Perinatal depression, Maternal mental health, Substance use
Plan
Vol 83
P. 148-155 - juillet 2023 Retour au numéro
Article précédent
- The Multi-dimensional Assessment of Suicide Risk in Chronic illness-20 (MASC-20): Development and validation
- Eun-Jung Shim, Hyeju Ha, Bo-ram Kim, Sun Mi Kim, Jung Yoon Moon, Jin Ho Hwang, Bong-Jin Hahm
- Association between thyroid autoimmunity and clinical characteristics in first-episode and drug-naive depressed patients with suicide attempts
- Xue-Zhu Feng, Ke Wang, Zhe Li, Fei Wang, Zi-Yi Li, Xuan Tan, Wei-Li Zhu, Xiang-Yang Zhang, Su-Xia Li
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?